cGMPs / Facilty Design & Management

Compliance and Traceability in Drug Manufacturing

What was once viewed as a “necessary evil” or a cost of doing business is increasingly being seen as a key competitive advantage, although hurdles remain.

By Matthew Littlefield, Manufacturing Research Analyst, the Aberdeen Group

Click the Download Now button below to access this 6-page, 2.6 MB pdf document.

Free Subscriptions

Pharma Manufacturing Digital Edition

Access the entire print issue on-line and be notified each month via e-mail when your new issue is ready for you. Subscribe Today. E-Newsletters

A mix of feature articles and current new stories that are critical to staying up-to-date on the industry, delivered to your inbox. Choose from an assortment of different topics and frequencies. Subscribe Today.